{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:49:21Z","timestamp":1794638961704,"version":"4.9.1"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1309\/c38d-d8j3-ju3e-v6ee","type":"journal-article","created":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T14:42:18Z","timestamp":1082040138000},"page":"380-389","source":"Crossref","is-referenced-by-count":60,"title":["The Immunophenotype of 325 Adult Acute Leukemias"],"prefix":"10.1093","volume":"117","author":[{"given":"Renate","family":"Thalhammer-Scherrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlinde","family":"Mitterbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Simonitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Fonatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Schwarzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,3,1]]},"reference":[{"key":"E00001","first-page":"2150","author":"Claxton, DF","year":"1995","unstructured":"Claxton DF, Albitar M. Acute leukemias: phenotyping and genotyping. Leukemia. 1995;9:2150-2152.","journal-title":"Leukemia"},{"key":"E00002","first-page":"2154","author":"Pui, CH","year":"1995","unstructured":"Pui CH, Campana D, Crist WM. Toward a clinically useful classification of acute leukemias. Leukemia. 1995;9:2154-2157.","journal-title":"Leukemia"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.leu.2400893","volume":"12","author":"Casasnovas","year":"1998","unstructured":"Casasnovas RO, Campos L, Mugneret F, et al. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients. Leukemia. 1998;12:34-42.","journal-title":"Leukemia"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood.V80.2.470.470","volume":"80","author":"Kita","year":"1992","unstructured":"Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood. 1992;80:470-477.","journal-title":"Blood"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1182\/blood.V80.12.3182.3182","volume":"80","author":"Hurwitz","year":"1992","unstructured":"Hurwitz CA, Raimondi SC, Head D, et al. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood. 1992;80:3182-3188.","journal-title":"Blood"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1182\/blood.V81.11.3083.3083","author":"Reading, CL","year":"1993","unstructured":"Reading CL, Estey EH, Huh YO, et al. Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood. 1993;81:3083-3090.","journal-title":"Blood"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood.V81.11.3043.3043","volume":"81","author":"Adriaansen","year":"1993","unstructured":"Adriaansen HJ, te Boekhorst PAW, Hagemeijer AM, et al. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13;q22) exhibits a specific immunophenotype with CD2 expression. Blood. 1993;81:3043-3051.","journal-title":"Blood"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood.V77.10.2242.2242","author":"Ball, ED","year":"1991","unstructured":"Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood. 1991;77:2242-2250.","journal-title":"Blood"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood.V80.3.582.582","volume":"80","author":"Claxton","year":"1992","unstructured":"Claxton DF, Reading CL, Nagarajan L, et al. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood. 1992;80:582-586.","journal-title":"Blood"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.1999.17.1.293","volume":"17","author":"Murray","year":"1999","unstructured":"Murray CK, Estey E, Paietta E, et al. CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome? J Clin Oncol. 1999;17:293-297.","journal-title":"J Clin Oncol"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood.V81.9.2399.2399","volume":"81","author":"Kita","year":"1993","unstructured":"Kita K, Miwa H, Nakase K, et al. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood. 1993;81:2399-2405.","journal-title":"Blood"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2141.1990.tb06365.x","volume":"76","author":"Geller","year":"1990","unstructured":"Geller RB, Zahurak M, Hurwitz CA, et al. Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: the significance of the stem-cell glycoprotein CD34 (My10). Br J Haematol. 1990;76:340-347.","journal-title":"Br J Haematol"},{"key":"E00013","first-page":"542","volume":"8","author":"Griesinger","year":"1994","unstructured":"Griesinger F, Elfers H, Ludwig WD, et al. Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11). Leukemia. 1994;8:542-548.","journal-title":"Leukemia"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ajcp\/109.2.211","author":"Khalidi, HS","year":"1998","unstructured":"Khalidi HS, Medeiros LJ, Chang KL, et al. The immunophenotype of adult acute myeloid leukemia. Am J Clin Pathol. 1998;109:211-220.","journal-title":"Am J Clin Pathol"},{"key":"E00015","first-page":"1898","volume":"92","author":"Ludwig","year":"1998","unstructured":"Ludwig WD, Rieder H, Bartram CR, et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German Multicenter trials GMALL 03\/87 and 04\/89. Blood. 1998;92:1898-1909.","journal-title":"Blood"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01696228","author":"Stasi, R","year":"1995","unstructured":"Stasi R, Taylor CG, Venditti A, et al. Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia. Ann Hematol. 1995;71:13-27.","journal-title":"Ann Hematol"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood.V90.8.2863","author":"Jennings, CD","year":"1997","unstructured":"Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood. 1997;90:2863-2892.","journal-title":"Blood"},{"key":"E00018","first-page":"79","author":"Stasi, R","year":"1995","unstructured":"Stasi R, Del Poeta G, Venditti A, et al. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques. Hematol Pathol. 1995;9:79-94.","journal-title":"Hematol Pathol"},{"key":"E00019","first-page":"823","volume":"8","author":"Seymour","year":"1994","unstructured":"Seymour JF, Pierce SA, Kantarjian HM, et al. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia. 1994;8:823-826.","journal-title":"Leukemia"},{"key":"E00020","first-page":"1735","volume":"9","author":"Kornblau","year":"1995","unstructured":"Kornblau SM, Thall P, Huh YO, et al. Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with \"optimal\" cutpoint analysis reveals absence of prognostic significance. Leukemia. 1995;9:1735-1741.","journal-title":"Leukemia"},{"key":"E00021","first-page":"388","author":"Del Poeta, G","year":"1994","unstructured":"Del Poeta G, Stasi R, Venditti A, et al. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia. 1994;8:388-394.","journal-title":"Leukemia"},{"key":"E00022","first-page":"388","author":"Del Poeta, G","year":"1994","unstructured":"Miwa H, Kita K, Nishii K, et al. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia\/acute lymphoblastic leukemia. Blood.","journal-title":"Leukemia"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0165-4608(86)90178-0","volume":"23","author":"First MIC Cooperative Study","year":"1986","unstructured":"First MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias: report of the workshop held in Leuven, Belgium, April 22-23, 1985. Cancer Genet Cytogenet. 1986;23:189-197.","journal-title":"Cancer Genet Cytogenet"},{"key":"E00024","first-page":"489","author":"Drexler, HG","year":"1993","unstructured":"Drexler HG, Thiel E, Ludwig WD. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia. 1993;7:489-498.","journal-title":"Leukemia"},{"key":"E00025","first-page":"637","author":"Drexler, HG","year":"1991","unstructured":"Drexler HG, Thiel E, Ludwig WD. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia. 1991;5:637-645.","journal-title":"Leukemia"},{"key":"E00026","first-page":"877","author":"Rothe, G","year":"1996","unstructured":"Rothe G, Schmitz G, for the Working Group on Flow Cytometry and Image Analysis. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia. 1996;10:877-895.","journal-title":"Leukemia"},{"key":"E00027","first-page":"2147","author":"Paietta, E","year":"1995","unstructured":"Paietta E. Proposals for the immunological classification of acute leukemias. Leukemia. 1995;9:2147-2148.","journal-title":"Leukemia"},{"key":"E00028","first-page":"170","volume":"3","author":"Janossy","year":"1989","unstructured":"Janossy G, Coustan-Smith E, Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia. 1989;3:170-181.","journal-title":"Leukemia"},{"key":"E00029","first-page":"1783","author":"Bene, MC","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Leukemia. 1995;9:1783-1786.","journal-title":"Leukemia"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01714978","volume":"62","author":"Catovsky","year":"1991","unstructured":"Catovsky D, Matutes E, Buccheri V, et al. A classification of acute leukaemia for the 1990s. Ann Hematol. 1991;62:16-21.","journal-title":"Ann Hematol"},{"key":"E00031","first-page":"451","author":"Co-operative, Group","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al, for the French-American-British (FAB) Co-operative Group. Proposals for the classification of acute leukaemias. Br J Haematol. 1976;33:451-458.","journal-title":"Br J Haematol"},{"key":"E00032","first-page":"626","author":"Bennett, JM","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report from the French-American-British Cooperative Group. Ann Intern Med. 1985;103:626-629.","journal-title":"Ann Intern Med"},{"key":"E00033","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7326\/0003-4819-103-3-460","volume":"103","author":"Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Criteria for diagnosis of acute leukemia of megakaryocyte lineage (M7): a report from the French-American-British Cooperative Group. Ann Intern Med. 1985;103:460-462.","journal-title":"Ann Intern Med"},{"key":"E00034","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.1991.tb04444.x","volume":"78","author":"Cooperative","year":"1991","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al, for the French-American-British (FAB) Cooperative Group. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol. 1991;78:325-329.","journal-title":"Br J Haematol"},{"key":"E00035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cyto.990180402","author":"Knapp, W","year":"1994","unstructured":"Knapp W, Strobl H, Majdic O. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry. 1994;18:187-198.","journal-title":"Cytometry"},{"key":"E00036","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/sj.leu.2401542","volume":"13","author":"Mitterbauer","year":"1999","unstructured":"Mitterbauer G, Zimmer C, Fonatsch C, et al. Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute leukemia by RT-PCR. Leukemia. 1999;13:1519-1524.","journal-title":"Leukemia"},{"key":"E00037","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1182\/blood.V81.11.2860.2860","volume":"81","author":"Downing","year":"1993","unstructured":"Downing JR, Head DR, Curcio-Brint AM, et al. An AML1\/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood. 1993;81:2860-2865.","journal-title":"Blood"},{"key":"E00038","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.1998.16.4.1519","volume":"16","author":"Laczika","year":"1998","unstructured":"Laczika K, Novak M, Hilgarth B, et al. Competitive CBFbeta\/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion (16): a pilot study. J Clin Oncol. 1998;16:1519-1525.","journal-title":"J Clin Oncol"},{"key":"E00039","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2141.1994.tb05048.x","volume":"88","author":"Korninger","year":"1994","unstructured":"Korninger L, Knobl P, Laczika K, et al. PML-RAR alpha PCR positivity in bone marrow of patients with APL precedes haematological relapse by 2-3 months. Br J Haematol. 1994;88:427-431.","journal-title":"Br J Haematol"},{"key":"E00040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V72.2.579.579","author":"Cross, AH","year":"1988","unstructured":"Cross AH, Goorha RM, Nuss R, et al. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood. 1988;72:579-587.","journal-title":"Blood"},{"key":"E00041","first-page":"1165","author":"Ribrag, V","year":"1992","unstructured":"Ribrag V, Bayle C, Brault P, et al. Acute myelogenous leukemia with T-cell features. Bull Cancer. 1992;79:1165-1171.","journal-title":"Bull Cancer"},{"key":"E00042","first-page":"1105","volume":"149","author":"Arber","year":"1996","unstructured":"Arber DA, Jenkins KA, Slovak ML. CD79alpha expression in acute myeloid leukemia. Am J Pathol. 1996;149:1105-1110.","journal-title":"Am J Pathol"},{"key":"E00043","first-page":"4162a","volume":"94","author":"Voliotis","year":"1999","unstructured":"Voliotis D, Horn PA, Kraemer H, et al. Early B-cell antigen CD79a expression in acute myeloid leukemia (AML) blasts is not compatible with the EGIL classification proposal for phenotypization of acute leukemias: is a revision necessary [abstract]? Blood. 1999;94(suppl 1):4162a.","journal-title":"Blood"},{"key":"E00044","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-0320(19971015)30:5<236::AID-CYTO4>3.0.CO;2-F","author":"Borowitz, MJ","year":"1997","unstructured":"Borowitz MJ, Bray R, Gascoyne R, et al. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry. 1997;30:236-244.","journal-title":"Cytometry"},{"key":"E00045","first-page":"1024","author":"Bene, MC","year":"1999","unstructured":"Bene MC, Bernier M, Castoldi G, et al. Impact of immunophenotyping on management of acute leukemias. Haematologica. 1999;84:1024-1034.","journal-title":"Haematologica"},{"key":"E00046","year":"1993","unstructured":"Drexler HG, Ludwig WD. Incidence and clinical relevance of myeloid antigen-positive ALL. In Ludwig WD, Thiel E, eds. Recent Advances in Cell Biology of Acute Leukemia: Impact on Clinical Diagnosis and Therapy. Berlin, Germany: Springer Verlag; 1993:53-66."},{"key":"E00047","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/10428199809092688","volume":"28","author":"Lenormand","year":"1998","unstructured":"Lenormand B, Bene MC, Lesesve JF, et al. PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. Leuk Lymphoma. 1998;28:329-342.","journal-title":"Leuk Lymphoma"},{"key":"E00048","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/10428199209053620","volume":"7","author":"Pui, CH","year":"1992","unstructured":"Pui CH. Acute leukemias with the t(4;11)(q21;q23). Leuk Lymphoma. 1992;7:173-179.","journal-title":"Leuk Lymphoma"},{"key":"E00049","first-page":"24","volume":"1","author":"Hagemeijer","year":"1987","unstructured":"Hagemeijer A, van Dongen JJ, Slater RM, et al. Characterization of the blast cells in acute leukemia with translocation (4;11): report of eight additional cases and one case with a variant translocation. Leukemia. 1987;1:24-31.","journal-title":"Leukemia"},{"key":"E00050","first-page":"3931","volume":"93","author":"Czuczman","year":"1999","unstructured":"Czuczman MS, Dodge RK, Stewart CC, et al. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8364. Blood. 1999;93:3931-3939.","journal-title":"Blood"},{"key":"E00051","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/1097-0142(19951101)76:9<1564::AID-CNCR2820760911>3.0.CO;2-1","author":"Preti, HA","year":"1995","unstructured":"Preti HA, Huh YO, O'Brien SM, et al. Myeloid markers in adult acute lymphocytic leukemia. Cancer. 1995;76:1564-1570.","journal-title":"Cancer"},{"key":"E00052","first-page":"2118","author":"Boldt, DH","year":"1994","unstructured":"Boldt DH, Kopecky KJ, Head D, et al. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults: the Southwest Oncology Group experience. Leukemia. 1994;8:2118-2126.","journal-title":"Leukemia"},{"key":"E00053","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1309\/MFCP-7GMW-AQM4-ED3N","volume":"114","author":"Kraguljac","year":"2000","unstructured":"Kraguljac N, Marisavljevic D, Jankovic G, et al. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia. Am J Clin Pathol. 2000;114:29-34.","journal-title":"Am J Clin Pathol"},{"key":"E00054","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s002770050508","volume":"78","author":"Garcia Vela","year":"1999","unstructured":"Garcia Vela JA, Martin M, Delgado I, et al. Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13(-), CD14 (-), and CD33 (-). Ann Hematol. 1999;78:237-240.","journal-title":"Ann Hematol"},{"key":"E00055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ajcp\/107.1.68","volume":"107","author":"Arber","year":"1997","unstructured":"Arber DA, Glackin C, Lowe G, et al. Presence of t(8;21)(q22;q22) in myeloperoxidase-positive, myeloid surface antigen-negative acute myeloid leukemia. Am J Clin Pathol. 1997;107:68-73.","journal-title":"Am J Clin Pathol"},{"key":"E00056","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2141.1992.tb08242.x","volume":"81","author":"Seshi","year":"1992","unstructured":"Seshi B, Kashyap A, Bennett JM. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14(-), and CD33 (-). Br J Haematol. 1992;81:374-377.","journal-title":"Br J Haematol"},{"key":"E00057","first-page":"1832","author":"Del Veccio, L","year":"1996","unstructured":"Del Veccio L, Di Noto R, Lo Pardo C, et al. Immunological classification of acute leukemias: comments on the EGIL proposals. Leukemia. 1996;10:1832-1833.","journal-title":"Leukemia"},{"key":"E00058","first-page":"815","author":"Del Veccio, L","year":"1991","unstructured":"Del Veccio L, Finizio O, Lo Pardo C, et al. Co-ordinate expression of T-cell antigens on acute myelogenous leukemia and of myeloid antigens on T-acute lymphoblastic leukemia; speculation on a highly balanced bilinearity. Leukemia. 1991;5:815-818.","journal-title":"Leukemia"},{"key":"E00059","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1182\/blood.V85.12.3688.bloodjournal85123688","volume":"85","author":"Cuneo","year":"1995","unstructured":"Cuneo A, Ferrant A, Michaux JL, et al. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings. Blood. 1995;85:3688-3694.","journal-title":"Blood"},{"key":"E00060","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2141.1989.tb00284.x","volume":"73","author":"Lo Coco","year":"1989","unstructured":"Lo Coco F, De Rossi G, Pasqualetti D, et al. CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity. Br J Haematol. 1989;73:480-485.","journal-title":"Br J Haematol"},{"key":"E00061","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood.V82.8.2595a.2595a","volume":"82","author":"Paietta","year":"1993","unstructured":"Paietta E, Wiernik PH, Andersen J, et al. Acute myeloid leukemia M4 with inv(16)(p13;q22) exhibits a specific immunophenotype with CD2 expression [letter]. Blood. 1993;82:2595.","journal-title":"Blood"},{"key":"E00062","first-page":"1108","author":"Paietta, E","year":"1994","unstructured":"Paietta E, Andersen J, Gallagher R, et al. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia. 1994;8:1108-1112.","journal-title":"Leukemia"},{"key":"E00063","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1097-0320(20000415)42:2<106::AID-CYTO3>3.0.CO;2-S","volume":"42","author":"Exner","year":"2000","unstructured":"Exner M, Thalhammer R, Kapiotis S, et al. The \"typical\" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant? Cytometry. 2000;42:106-109.","journal-title":"Cytometry"},{"key":"E00064","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V84.1.244.244","volume":"84","author":"Scott","year":"1994","unstructured":"Scott AA, Head DR, Kopecky KJ, et al. HLA-DR-, CD33+, CD56+, CD16- myeloid\/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994;84:244-255.","journal-title":"Blood"},{"key":"E00065","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood.V90.6.2417","volume":"90","author":"Suzuki","year":"1997","unstructured":"Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid\/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997;90:2417-2428.","journal-title":"Blood"},{"key":"E00066","first-page":"13","author":"Mirro, J","year":"1992","unstructured":"Mirro J. Pathology and immunology of acute leukemia. Leukemia. 1992;6(suppl 2):13-15.","journal-title":"Leukemia"},{"key":"E00067","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1200\/JCO.1990.8.5.813","author":"Cheson, BD","year":"1990","unstructured":"Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813-819.","journal-title":"J Clin Oncol"},{"key":"E00068","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting--Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.","journal-title":"J Clin Oncol"},{"key":"E00069","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/07357909709039744","author":"Jennings, CD","year":"1997","unstructured":"Jennings CD, Foon KA. Flow cytometry: recent advances in diagnosis and monitoring of leukemia. Cancer Invest. 1997;15:384-399.","journal-title":"Cancer Invest"},{"key":"E00070","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ajcp\/100.5.534","author":"Borowitz, MJ","year":"1993","unstructured":"Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis. Am J Clin Pathol. 1993;100:534-540.","journal-title":"Am J Clin Pathol"},{"key":"E00071","first-page":"487","author":"Second MIC Cooperative Study, Group","year":"1988","unstructured":"Second MIC Cooperative Study Group. Morphologic, immunologic and cytogenetic (MIC) working classification of acute myeloid leukaemias. Br J Haematol. 1988;68:487-494.","journal-title":"Br J Haematol"},{"key":"E00072","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10428199509075307","author":"Gassmann, W","year":"1995","unstructured":"Gassmann W, L&ouml;ffler H. Acute megakaryoblastic leukemia. Leuk Lymphoma. 1995;18:69-73.","journal-title":"Leuk Lymphoma"},{"key":"E00073","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1309\/2FYJ-00BE-R8N0-HMPQ","volume":"113","author":"Kotylo","year":"2000","unstructured":"Kotylo PK, Seo IS, Smith FO, et al. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0). Am J Clin Pathol. 2000;113:193-200.","journal-title":"Am J Clin Pathol"},{"key":"E00074","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ajcp\/109.1.32","author":"Cohen, PL","year":"1998","unstructured":"Cohen PL, Hoyer JD, Kurtin PJ, et al. Acute myeloid leukemia with minimal differentiation. Am J Clin Pathol. 1998;109:32-38.","journal-title":"Am J Clin Pathol"},{"key":"E00075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood.V89.2.621","volume":"89","author":"Venditti","year":"1997","unstructured":"Venditti A, Del Poeta G, Buccisano F, et al. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes. Blood. 1997;89:621-629.","journal-title":"Blood"},{"key":"E00076","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s002770050162","volume":"72","author":"Amadori","year":"1996","unstructured":"Amadori S, Venditti A, Del Poeta G, et al. Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosis. Ann Hematol. 1996;72:208-215.","journal-title":"Ann Hematol"},{"key":"E00077","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2141.2001.02801.x","volume":"113","author":"Bene","year":"2001","unstructured":"Bene MC, Bernier M, Casasnovas RO, et al. Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients. Br J Haematol. 2001;113:737-745.","journal-title":"Br J Haematol"},{"key":"E00078","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.leu.2401074","author":"Villamor, N","year":"1998","unstructured":"Villamor N, Zarco MA, Rozman M, et al. Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics. Leukemia. 1998;12:1071-1075.","journal-title":"Leukemia"},{"key":"E00079","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10428199409059594","author":"Praxedes, MK","year":"1994","unstructured":"Praxedes MK, Zimermnan De Oliveira L, Da Veiga Pereira W, et al. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia. Leuk Lymphoma. 1994;12:233-239.","journal-title":"Leuk Lymphoma"},{"key":"E00080","first-page":"1640","author":"Matutes, E","year":"1994","unstructured":"Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8:1640-1645.","journal-title":"Leukemia"},{"key":"E00081","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H","author":"Campana, D","year":"1999","unstructured":"Campana D, Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry. 1999;38:139-152.","journal-title":"Cytometry"},{"key":"E00082","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","author":"Coustan-Smith, E","year":"1998","unstructured":"Coustan-Smith E, Behm FG, Sanchez J, et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet. 1998;351:550-554.","journal-title":"Lancet"},{"key":"E00083","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.V90.6.2465","author":"San Miguel, JF","year":"1997","unstructured":"San Miguel JF, Martinez A, Macedo A, et al. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood. 1997;90:2465-2470.","journal-title":"Blood"},{"key":"E00084","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.1996.d01-1962.x","volume":"95","author":"Kluin-Nelemans","year":"1996","unstructured":"Kluin-Nelemans JC, Van Wering ER, Van't Veer MB, et al. Pitfalls in the immunophenotyping of leukaemia and leukaemic lymphomas: survey of 9 years of quality control in the Netherlands. Br J Haematol. 1996;95:692-699.","journal-title":"Br J Haematol"},{"key":"E00085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0320(19971015)30:5<231::AID-CYTO3>3.0.CO;2-K","author":"Stewart, CC","year":"1997","unstructured":"Stewart CC, Behm FG, Carey JL, et al. US-Canadian Consensus Recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry. 1997;30:231-235.","journal-title":"Cytometry"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/117\/3\/380\/4984517\/ajcpath117-0380.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:39:17Z","timestamp":1585701557000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/C38D-D8J3-JU3E-V6EE"}},"subtitle":["Relationship to Morphologic and Molecular Classification and Proposal for a Minimal Screening Program Highly Predictive for Lineage Discrimination"],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":85,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2002,3,1]]},"published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1309\/C38D-D8J3-JU3E-V6EE"],"URL":"https:\/\/doi.org\/10.1309\/c38d-d8j3-ju3e-v6ee","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}